Logo

American Heart Association

  2
  0


Final ID: 4137205

Management Patterns and Outcomes in the Use of Invasive Mechanical Ventilation for Patients with Cardiogenic Shock

Abstract Body (Do not enter title and authors here): Background: Approximately half of all patients with cardiogenic shock (CS) require invasive mechanical ventilation (IMV). While there have been significant advances in the management of patients requiring IMV based on data primarily derived from medical intensive care patients with respiratory failure, little is known regarding the management and outcomes of IMV in patients with CS.

Methods: We conducted an analysis of patients treated for CS who required IMV at an academic safety net hospital from 2017-2023. Indications for IMV, ventilator settings, and medications were obtained from the medical record. The primary outcome was unsuccessful extubation, defined as reintubation within 48 hours of extubation.

Results: A total of 110 patients with CS who received IMV were identified. Median age was 60yo; 28% of the cohort was female, 39% of Hispanic ethnicity, and 38% of Black race. Primary reasons for intubation included ongoing cardiac arrest (35%) and hypoxic respiratory failure (34%). Most patients were on minimal ventilator support at 24 hours after intubation (median FiO2 40% [IQR 30-50%], post-end expiratory pressure [PEEP] 5cm H2O [IQR 5-8]). Mechanical circulatory support (MCS) was present in 40% of patients at 24 hours post-intubation. Protocolized spontaneous breathing trials (SBTs) were delayed in 77% of patients, primarily due to hemodynamic instability (88%). Planned or unplanned extubation occurred in 63% of patients after a median of 4.8 days [IQR 2.1-8.0]. Ten percent of patients transferred hospitals while on IMV, while 27% were palliatively extubated or died on IMV. The majority (58%) of patients undergoing non-palliative extubation were on vasoactive medications preceding extubation, with only 2% on MCS. Most patients (58%) were extubated to nasal cannula or room air. A total of 13% of patients experienced unsuccessful extubation.

Conclusions: In a cohort of patients with CS requiring IMV, most patients were on minimal ventilator settings within 24 hours yet remained intubated with SBTs delayed due to hemodynamic instability. Rates of failed extubation were comparable to published data from other forms of critical illness. Further work is necessary to determine optimal approaches to ventilator liberation and circulatory support in intubated patients with CS where hemodynamic derangements rather than respiratory insufficiency represent the primary barrier to extubation.
  • Tucker, Grant  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Hendren, Nicholas  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Grodin, Justin  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Thibodeau, Jennifer  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Navar, Ann Marie  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Farr, Maryjane  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Das, Sandeep  ( University of Texas Southwestern , Dallas , Texas , United States )
  • De Lemos, James  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Hall, Eric  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Grubb, Christopher  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Bionghi, Neda  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Chen, Catherine  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Lussier, Bethany  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Kershaw, Corey  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Ratti, Gregory  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Mehta, Roma  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Ayers, Colby  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Grant Tucker: DO NOT have relevant financial relationships | Nicholas Hendren: DO have relevant financial relationships ; Independent Contractor:Tosoh:Active (exists now) ; Research Funding (PI or named investigator):TriCog Health:Active (exists now) | Justin Grodin: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Consultant:Sarepta:Past (completed) ; Consultant:Tenax:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Alexion:Active (exists now) ; Consultant:Alnylam:Past (completed) ; Consultant:Astra-Zeneca:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Eidos/BridgeBio:Past (completed) | Jennifer Thibodeau: DO NOT have relevant financial relationships | Ann Marie Navar: DO have relevant financial relationships ; Consultant:Amgen, Bayer, Eli Lilly, Esperion, Janssen, Merck, New Amsterdam, Novo Nordisk, Novartis, Pfizer, and Silence Therapeutics:Active (exists now) ; Researcher:Amgen, Esperion:Active (exists now) | Maryjane Farr: DO have relevant financial relationships ; Consultant:TransMedics:Active (exists now) ; Consultant:Natera:Active (exists now) | Sandeep Das: DO NOT have relevant financial relationships | James de Lemos: DO have relevant financial relationships ; Consultant:Amgen, Inc.:Active (exists now) ; Consultant:Siemen's:Past (completed) ; Consultant:Cytokinetics:Past (completed) ; Researcher:Abbott:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:Novo Nordisc:Active (exists now) ; Consultant:Varian Medical Systems:Active (exists now) ; Consultant:Johnson and Johnson:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Regerenon Pharmaceuticals:Active (exists now) | Eric Hall: DO NOT have relevant financial relationships | Christopher Grubb: No Answer | Neda Bionghi: No Answer | Catherine Chen: DO NOT have relevant financial relationships | Bethany Lussier: DO have relevant financial relationships ; Consultant:Biogen:Active (exists now) | Corey Kershaw: DO NOT have relevant financial relationships | Gregory Ratti: DO NOT have relevant financial relationships | Roma Mehta: No Answer | Colby Ayers: DO have relevant financial relationships ; Consultant:NIH:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Shocking Developments in Cardiogenic Shock

Monday, 11/18/2024 , 01:30PM - 02:45PM

Abstract Oral Session

More abstracts on this topic:
Prehospital advanced airway management across age groups in out-of-hospital cardiac arrest: Registry-based cohort study from the Resuscitation Outcomes Consortium Epidemiologic Registry

Izawa Junichi, Komukai Sho, Callaway Clifton, Okubo Masashi

Chest Compression Fraction, Bag-mask Ventilation, And Survival From Out-of-hospital Cardiac Arrest: A Multicenter Study

Yang Betty, Vaillancourt Christian, Callaway Clifton, Salcido David, Carson Jonas, Blackwood Jennifer, Wang Henry, Idris Ahamed, Aramendi Elisabete, Leroux Brian, Jaureguibeitia Xabier, Shaver Sarah, Chang Mary, Rea Thomas, Kudenchuk Peter, Christenson Jim

More abstracts from these authors:
Trends in Survival After Out-of-Hospital Cardiac Arrest Across Community Demographics Since the COVID-19 Pandemic

Hall Eric, Li Qiang, Chan Paul, Mcnally Bryan, Al-araji Rabab, De Lemos James, Girotra Saket

Aging Alone: Impact of Social Networks on Older Adults with Advanced Heart Failure

Godfrey Sarah, Drazner Mark, Farr Maryjane, Jawaid Anas, Maini Mansi, Zhang Jingwen, Dutta Manasa, Wrobel Christopher, Thibodeau Jennifer, Grodin Justin, Morlend Robert

You have to be authorized to contact abstract author. Please, Login
Not Available